Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Development of a Biosensor for Anthrax Therapeutics and Diagnostics, 36128 [05-12308]

Download as PDF 36128 ACTION: Federal Register / Vol. 70, No. 119 / Wednesday, June 22, 2005 / Notices Notice. DEPARTMENT OF DEFENSE Name of Committee: The Defense Advisory Committee on Military Compensation (DACMC). Committee Membership: Chairman: ADM (Ret) Donald L. Pilling. Members: Dr. John P. White; Gen (Ret) Lester L. Lyles; Mr. Frederic W. Cook; Dr. Walter Oi; Dr. Martin Anderson; and Mr. Joseph E. Jannotta. General Function of the Committee: The Committee will provide the Secretary of Defense, through the Under Secretary of Defense (Personnel and Readiness), with assistance and advice on matters pertaining to military compensation. The Committee will examine what types of military compensation and benefits are the most effective for meeting the needs of the Nation. Date and Time: Wednesday, July 20, 2005, from 10 a.m. to 12 p.m. (morning session) and 1 p.m. to 3 p.m. (afternoon session). Location: Crystal City Hilton, 2399 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Mr. Terry Mintz, Designated Federal Official, Defense Advisory Committee on Military Compensation, 2521 S. Clark Street, Arlington, VA 22202. Telephone (703) 699–2700. Agenda: On July 20, 2005, from 10 a.m. to 12 p.m. and 1 p.m. to 3 p.m., the Committee will discuss various aspects of the military pay and benefits system, specifically concerning issues identified during fact-finding briefings conducted at the June meeting. Procedure: Public participation in Committee discussions at this meeting will not be permitted. Written submissions of data, information, and views may be sent to the Committee’s contact person at the address shown. Submissions be received by close of business July 15, 2005. Persons attending are advised that the Committee is not responsible for providing access to electrical outlets. SUMMARY: FOR FURTHER INFORMATION CONTACT: Mr. Terry Mintz at (703) 699–2700. Dated: June 16, 2005. L.M. Bynum, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 05–12244 Filed 6–21–05; 8:45 am] BILLING CODE 5001–06–M VerDate jul<14>2003 21:12 Jun 21, 2005 Jkt 205001 Department of the Army Reserve Officers’ Training Corps (ROTC) Program Subcommittee Department of the Army, DoD. Notice of open meeting. AGENCY: ACTION: SUMMARY: In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C., App. 2), announcement is made of the following Committee meeting: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–ZA–J, 504 Scott Street, Fort Detrick, Frederick, MD 21702–5012. ADDRESSES: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: This biosensor can be used for several different purposes namely: (1) Study toxin protein-protein interactions; (2) Screen anthrax therapeutic molecules such as antibodies and small molecules; (3) As a diagnostic tool to detect anthrax toxins in blood or urine samples. Name of Committee: Reserve Officers’ Training Corps (ROTC) Program Subcommittee. Dates of Meeting: July 6–7, 2005. Location: Sheraton Tacoma Hotel, 1320 Broadway Plaza, Tacoma, Wa 98402. Time: 0800–1700 hours, July 6, 2005; 0800–1700 hours July 7, 2005. Proposed Agenda: Review and discuss academic accreditation agencies and procedures; development of Military Science and Leadership as a minor; incentive based scholarship initiatives; and observe ROTC cadet training at the Leadership Development and Assessment Course (LDAC), Fort Lewis, WA. SUPPLEMENTARY INFORMATION: Mr. Pierre Blackwell, U.S. Army Cadet Command (ATCC–TR), Fort Monroe, VA 23651 at (757) 788–4326. SUPPLEMENTARY INFORMATION: This meeting is open to the public. Any interested person may attend, appear before, or file statements with the committee. DEPARTMENT OF DEFENSE FOR FURTHER INFORMATION CONTACT: Radames Cornier, Jr., Colonel, GS Chief of Staff. [FR Doc. 05–12305 Filed 6–21–05; 8:45 am] BILLING CODE 3710–08–M DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Development of a Biosensor for Anthrax Therapeutics and Diagnostics Department of the Army, DoD. ACTION: Notice AGENCY: SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 60/ 653,230 entitled ‘‘Development of a Biosensor for Anthrax Therapeutics and Diagnostics, filed February 14, 2005. The United States Government, as represented by the Secretary of the Army, has rights in this invention. PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 Brenda S. Bowen Army Federal Register Liaison Officer. [FR Doc. 05–12308 Filed 6–21–05; 8:45 am] BILLING CODE 3710–08–M Department of the Army Availability of Non-Exclusive, Exclusive License or Partially Exclusive Licensing of U.S. Patent Concerning Method and Apparatus for Making Body Heating and Cooling Garments AGENCY: ACTION: Department of the Army, DoD. Notice. SUMMARY: In accordance with 37 CFR Part 404.6, announcement is made of the availability for licensing of U.S. Patent No. US 6,901,608 B2 entitled ‘‘Method and Apparatus for Making Body Heating and Cooling Garments’’ issued June 7, 2005. This patent has been assigned to the United States Government as represented by the Secretary of the Army. Mr. Robert Rosendrans at U.S. Army Soldier Systems Center, Kansas Street, Natick, MA 01760, Phone: (508) 233–4938 or Email: Robert.Rosenkrans@natick.army.mil. FOR FURTHER INFORMATION CONTACT: Any licenses granted shall comply with 35 U.S.C. 209 and 37 CFR Part 404. SUPPLEMENTARY INFORMATION: Brenda S. Bowen Army Federal Register Liaison Officer. [FR Doc. 05–12309 Filed 6–21–05; 8:45 am] BILLING CODE 3710–08–M E:\FR\FM\22JNN1.SGM 22JNN1

Agencies

[Federal Register Volume 70, Number 119 (Wednesday, June 22, 2005)]
[Notices]
[Page 36128]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-12308]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Development 
of a Biosensor for Anthrax Therapeutics and Diagnostics

AGENCY: Department of the Army, DoD.

ACTION: Notice

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of the invention set forth in 
U.S. Provisional Patent Application Serial No. 60/653,230 entitled 
``Development of a Biosensor for Anthrax Therapeutics and Diagnostics, 
filed February 14, 2005. The United States Government, as represented 
by the Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: This biosensor can be used for several 
different purposes namely: (1) Study toxin protein-protein 
interactions; (2) Screen anthrax therapeutic molecules such as 
antibodies and small molecules; (3) As a diagnostic tool to detect 
anthrax toxins in blood or urine samples.

Brenda S. Bowen
Army Federal Register Liaison Officer.
[FR Doc. 05-12308 Filed 6-21-05; 8:45 am]
BILLING CODE 3710-08-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.